Thursday, October 28, 2021
Home Tags Biocon

Tag: Biocon

Biocon launches Everolimus tablets in US

Biocon today announced the launch of Everolimus tablets, a generic version of Afinitor, in the US, the company notified via a statement.

USFDA issues 6 observations to Biocon’s Malaysian facility

Biotechnology major Biocon on Saturday said the US health regulator has issued six observations after the inspection of the manufacturing facility of its Malaysian subsidiary Biocon Sdn Bhd....

Indian Pharma Industry go local for APIs: Seeking to end reliance...

Indian drug companies are looking to local makers of so-called active pharmaceutical ingredients (API) or trying to make them in-house in a bid to...

Indian Pharma firms to set local Mfg of APIs: No dependence...

Indian drug companies are looking to local makers of so-called active pharmaceutical ingredients (API) or trying to make them in-house in a bid to...

Syngene’s Covid test technology may hit market soon

Syngene’s Covid test technology may hit market soon BENGALURU: Biocon’s subsidiary Syngene has developed testing technology for coronavirus which it...

Biocon gets EIR from USFDA

Biocon Sdn Bhd, a subsidiary of Biocon has received the Establishment Inspection Report (EIR) from the US FDA for the pre-approval inspection...

Biocon gets EIR from USFDA for small molecules API

Biocon stated that it has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for the post...

Biocon receives 2 observations from USFDA

The United States Food and Drug Administration (USFDA) issued a Form 483 with two observations to Biocon’ Bengaluru API facility.

USFDA’s inspection of Biocon with 5 observations

New Delhi: Biocon Ltd said the US health regulator conducted a pre-approval inspection and good manufacturing practice (GMP) examination of the API manufacturing facility and...

Biocon: USFDA concludes with zero observations

NEW DELHI: Biocon said that pre-approval inspection of the Bengaluru facility of its arm conducted by US health regulator was concluded with zero observations.

Latest posts

FDA Haryana: Webinar organized for the Chemists of Haryana

A webinar was organized for the chemists of Ambala and Panchkula zones, Haryana by the Price Monitoring and Resource Unit (PMRU) working...

Authors

52 POSTS0 COMMENTS
30 POSTS0 COMMENTS
17 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS